Abstract
Blood coagulation time is an important factor to consider for postoperative and cardiac disorder patients who have been prescribed anticoagulant coagulant medications. The coagulation process is also known to be perturbed in some individuals with psychiatric disorders, such as schizophrenia. This chapter describes a patient self-management system for a functional assessment of blood coagulation activity, determining the appropriate anticoagulant dosages using a test strip device and the Coagu app. The app can also be used as a patient reminder of treatment times and to monitor treatment and effects over time.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
van Os J, Kapur S (2009) Schizophrenia. Lancet 374:635–645
Hoirisch-Clapauch S, Amaral OB, Mezzasalma MA, Panizzutti R, Nardi AE (2016) Dysfunction in the coagulation system and schizophrenia. Transl Psychiatry 6:e704. doi:10.1038/tp.2015.204
Jaros JA, Martins-de-Souza D, Rahmoune H, Rothermundt M, Leweke FM, Guest PC et al (2012) Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls. J Proteomics 76 Spec No:43–55. doi:10.1016/j.jprot.2012.05.027
Paradise HT, Berlowitz DR, Ozonoff A, Miller DR, Hylek EM, Ash AS et al (2014) Outcomes of anticoagulation therapy in patients with mental health conditions. J Gen Intern Med 29:855–861
Luchtman-Jones L, Broze GJ Jr (1995) The current status of coagulation. Ann Med 27:47–52
Chakrabarti R, Das SK (2007) Advances in antithrombotic agents. Cardiovasc Hematol Agents Med Chem 5:175–185
Jespersen J, Hansen MS, Dyerberg J, Ingerslev J, Jensen G, Jørgensen M et al (1991) Standardized prothrombin time determinations and optimal anticoagulant therapy. Ugeskr Laeger 153:355–360
van den Besselaar AM, Meeuwisse-Braun J, Schaefer-van Mansfeld H, van Rijn C, Witteveen E (2000) A comparison between capillary and venous blood international normalized ratio determinations in a portable prothrombin time device. Blood Coagul Fibrinolysis 11:559–562
Tideman PA, Tirimacco R, St John A, Roberts GW (2015) How to manage warfarin therapy. Aust Prescr 38:44–48
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Vegt, J., Guest, P.C. (2017). Development of a User-Friendly App for Testing Blood Coagulation Status in Schizophrenia Patients. In: Guest, P. (eds) Proteomic Methods in Neuropsychiatric Research. Advances in Experimental Medicine and Biology(), vol 974. Springer, Cham. https://doi.org/10.1007/978-3-319-52479-5_34
Download citation
DOI: https://doi.org/10.1007/978-3-319-52479-5_34
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52478-8
Online ISBN: 978-3-319-52479-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)